Genetically recessive mutant of human monocytic leukemia U937 resistant to tumor necrosis factor-α-induced apoptosis

被引:0
|
作者
Dong, J
Naito, M
Mashima, T
Jang, WH
Tsuruo, T
机构
[1] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan
[2] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 170, Japan
关键词
D O I
10.1002/(SICI)1097-4652(199802)174:2<179::AID-JCP5>3.0.CO;2-L
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumor necrosis factor-alpha (TNF-alpha) is a cytokine that induces apoptosis in various cell systems by binding to the TNF receptor (TNFR). To study TNF-alpha-induced apoptosis, we isolated and characterized a novel TNF-alpha-resistant variant, U937/TNF clone UA, from human monocytic leukemia U937 cells. The UA cells resist apoptosis induced by TNF-alpha and anti-fas antibody but not by anticancer drugs, such as VP-16 and Ara-C. Somatic cell hybridization between U937 and UA showed that apoptosis resistance to TNF-alpha in UA was genetically recessive. The hybridization analysis also showed that UA and another recessive mutant clone, UC, belong to different complementation groups in TNF-alpha-induced apoptosis signaling. In UA cells, TNF-alpha-induced disruption of mitochondrial membrane potential and CPP32 activation were abrogated. Expression of TNFR, Fas, and Bcl-2 family proteins was not changed in UA cells. These results suggest that the apoptosis resistant UA cells could have a functional defect in apoptosis signaling from the TN FR to mitochondria and interleukin-1 beta converting enzyme (ICE) family protease activation. UA cells could be used to study signaling linkage between cell death-inducing receptor and mitochondria. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 50 条
  • [21] Fatty acid induced changes of U937 monocytic leukemia cell proteome
    Orvietani, PL
    Susta, F
    Vecchini, A
    Ceccarelli, V
    Martelli, MP
    Binaglia, L
    CHEMISTRY AND PHYSICS OF LIPIDS, 2005, 136 (02) : 119 - 119
  • [22] TUMOR-NECROSIS-FACTOR INDUCES TISSUE FACTOR ACTIVITY IN HUMAN-LEUKEMIA CELL-LINE U937
    CONKLING, PR
    GREENBERG, CS
    WEINBERG, JB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 400 - 400
  • [23] DIFFERENTIATION AND DEDIFFERENTIATION OF THE HUMAN MONOCYTIC LEUKEMIA-CELL LINE, U937
    HOSOYA, H
    MARUNOUCHI, T
    CELL STRUCTURE AND FUNCTION, 1992, 17 (05) : 263 - 269
  • [24] TISSUE FACTOR-LIKE ACTIVITY OF THE HUMAN MONOCYTIC TUMOR-CELL LINE U937
    HUDIG, D
    RAPAPORT, SI
    BAJAJ, SP
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 33 - 33
  • [25] Dynamics of apoptotic events induced in human leukemia U-937 cells by tumor necrosis factor
    Kudryavets, YI
    Phylchenkov, AA
    Abramenko, IV
    Polischouk, LZ
    Slukvin, II
    Belous, NI
    EXPERIMENTAL ONCOLOGY, 1996, 18 (04): : 353 - 365
  • [26] TUMOR-NECROSIS-FACTOR-ALPHA INDUCES APOPTOSIS IN HIV-INFECTED U937 CELLS
    MALORNI, W
    RIVABENE, R
    RAINALDI, G
    SANTINI, MT
    DONELLI, G
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (01) : 118 - 119
  • [27] MOLECULAR CHARACTERIZATION OF U937 SUBCLONES RESISTANT TO TUMOR-NECROSIS-FACTOR OR INTERFERON-GAMMA
    KRONKE, M
    SCHUTZE, S
    SCHEURICH, P
    SCHLUTER, C
    UCER, U
    PFIZENMAIER, K
    IMMUNOBIOLOGY, 1986, 173 (2-5) : 122 - 123
  • [28] Infection by Candida albicans inhibits apoptosis of human monocytes and monocytic U937 cells
    Heidenreich, S
    Otte, B
    Lang, D
    Schmidt, M
    JOURNAL OF LEUKOCYTE BIOLOGY, 1996, 60 (06) : 737 - 743
  • [29] In vitro effects of sirolimus on apoptosis in human cultured monocytic U937 cell line
    de Cal, M.
    Corradi, V.
    Cruz, D.
    Nalesso, F.
    Kuang, D.
    Ocampo, C.
    Chiaramonte, S.
    Ronco, C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 268 - 269
  • [30] Isofraxidin enhances hyperthermia-induced apoptosis via redox modification in acute monocytic leukemia U937 cells
    Li, Peng
    Zhao, Qing-Li
    Rehman, Mati Ur
    Jawaid, Paras
    Cui, Zheng-Guo
    Ahmed, Kanwal
    Kondo, Takashi
    Saitoh, Jun-Ichi
    Noguchi, Kyo
    MOLECULAR MEDICINE REPORTS, 2023, 27 (02)